Alissa Cooper

Alissa Cooper is a medical doctor at the Thoracic Oncology and Phase 1 services at Dana-Farber Cancer Institute in Boston, USA. Previously, she served on the Thoracic Oncology and Early Drug Development Services at Memorial Sloan Kettering in New York.

Dr. Cooper leads clinical trials of novel therapies for thoracic and high-grade neuroendocrine cancers and is dedicated to personalized patient care and advancing research to improve outcomes.